Skip to content

PHARMACIE CHATELLE

Active Risk: not assessed Private limited companyfounded 2014active for 11 yearsG.J. Martinstraat 50, 1200 Woluwe-Saint-LambertKBO/BCE: BE 0506.720.179

Lifetime

11 annual accounts with figures on one time axis
peak of €229,261 in 2024
€170,132▼ 25.8%
lowest -€28,565 in 2015
€24,052▼ 74.2%
peak of €256,997 in 2023
€190,628▼ 6.4%
€446,546▼ 8.6%
peak of 0.8 FTE in 2024
0.8 FTEunchanged
Board2 names since 2014
2 directors and 1 other
Documentsfilings and deeds
30-07-20261 day before the deadline
2025abbreviated format
Gross margin from €229,261 to €170,132Result from €93,242 to €24,052Dividend €37,037

Key points

from the 2025 annual accounts

Equity

€190,628 ▼ 6.4%
203,6122024+24,052Profit-37,037Dividend190,6282025

PHARMACIE CHATELLE paid out €37,037 in dividends. That is 154% of the 2025 profit.

Result

€24,052 ▼ 74.2%
€93,2002024€24,1002025

The result fell in 2025 from €93,242 to €24,052.

Filings

11 annual accounts 12 filings since 2015
AprilJune31 JulyOctober201520202025

The last five annual accounts were filed 1 to 94 days before the end of the period.

Checked score

Outside the general model
Model not applicable to financial institutions
The Checked score measures liquidity, leverage and margins against the norms for trading and manufacturing companies. A bank, insurer or financial holding has a very different balance sheet. Those ratios and the score mean nothing here. So there is no financial strength either.

Bankruptcy probability within 12 months

The company is a financial institution: a bank, insurer or financial holding. Its balance sheet works differently from that of a trading or manufacturing company. A bankruptcy probability from the general model would mislead here.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director
  • 50 sharesdeed of 12-12-2014
  • 50 sharesdeed of 12-12-2014

Shares in 1 company,

Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0506720179
Merger: PHARMACIE CHATELLE takes over LUFAX Dissolution of the company · Company renamed to PHARMACIE CHATELLE · Dissolved without liquidation · General meeting of 27-03-2020 · Gazette deed
Merger proposal: AUVIVE takes over LUFAX The company holds all the shares of LUFAX · General meeting of 10-12-2019 · Gazette deed
Publication in the Belgian Official Gazette Gazette deed
All 24 events

Comparable companies

same main activity, similar in size and age
Company
PHARMACIE CHATELLE Woluwe-Saint-Lambert €0.6m €170,132 35.7% 0.8
BW GROEP Genk €0.8m €135,980 20.7% 0.9
VIKTHUR Bruges €0.8m €148,763 64.8% 1
NYMA Hoogstraten €0.7m €131,584 27.8% 1
RMB PROJECTS Oudsbergen €0.5m €162,493 59.6% 1
ZOEVA Wervik €0.9m €158,189 78.6% 0.6
GROUP XSP Genk €1.0m €208,703 27.9% 1

These companies have the same main activity as PHARMACIE CHATELLE: activities of holding companies (NACE 64210). They are comparable in size and age: total assets between €517,000 and €1m, founded between 2011 and 2017.

Official details

Source: KBO
Status
Active since 10-12-2014Normal situation
Activity
Activities of holding companiesNACE 64210and 1 other
Joint committee
313Pharmacies and pricing offices · annual accounts 2024
Establishment unit
2.237.479.9941200 Woluwe-Saint-Lambert, since 10-12-2014
Financial year end
31 December
Peppol
Reachable since 26-08-2025
Company details

Annual accounts 2025

€637,174▼ 8.0%
Employeeson 31-12-2025
1=
Filing
Filed on 30-07-2026, 120 days before the end of the filing period
Financials

Insights on PHARMACIE CHATELLE

PHARMACIE CHATELLE files the abbreviated format. That format states no turnover. The gross margin rose from -€14,651 in 2015 to €170,132 in 2025.

The balance sheet grew most from 2019 to 2020 through fixed assets, financed with long-term debt.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about PHARMACIE CHATELLE

What is the company number of PHARMACIE CHATELLE?
The company number of PHARMACIE CHATELLE is 0506.720.179. The VAT number is the same number with BE in front: BE 0506.720.179.
Where is PHARMACIE CHATELLE based?
The registered office is at G.J. Martinstraat 50, 1200 Woluwe-Saint-Lambert.Company details
What does PHARMACIE CHATELLE do?
According to the KBO register, the main activity is activities of holding companies (NACE 64210).
What is the legal form of PHARMACIE CHATELLE?
PHARMACIE CHATELLE is a private limited company (BV).
When was PHARMACIE CHATELLE founded?
PHARMACIE CHATELLE was founded on 10-12-2014.
Is PHARMACIE CHATELLE still active?
Yes, PHARMACIE CHATELLE is an active enterprise in the KBO register.
How many employees does PHARMACIE CHATELLE have?
PHARMACIE CHATELLE had an average of 0.8 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does PHARMACIE CHATELLE fall under?
In its 2024 annual accounts, PHARMACIE CHATELLE states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of PHARMACIE CHATELLE?
The turnover in financial year 2025 is ≈ €260,000. This figure is estimated from the gross margin of €170,132 and 33 comparable companies (NACE 64210). It probably lies between €230,000 and €330,000.
Is PHARMACIE CHATELLE profitable?
In financial year 2025, PHARMACIE CHATELLE made a profit of €24,052.
Where can I find the annual accounts of PHARMACIE CHATELLE?
PHARMACIE CHATELLE filed 12 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARMACIE CHATELLE due?
PHARMACIE CHATELLE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.